Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of anaemia with oral iron supplementation
ISRCTN16425597Phase 3Active, not recruiting
- Sponsor
- NHS Blood and Transplant
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferrous sulphate with Matched placebo (2 arms). Primary endpoint: Composite adverse pregnancy and neonatal outcome. Started Mar 2024; status: active, not recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ISRCTN16425597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16425597.